Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Update on prostaglandin analogs.

Camille Hylton1, Alan L Robin

  • 1The Johns Hopkins Wilmer Eye Institute, Baltimore, Maryland, USA.

Current Opinion in Ophthalmology
|April 17, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Remote Tonometry Identifies Significant Variability in the Timing of Intraocular Pressure Response to Topical Medication Change.

Ophthalmology. Glaucoma·2026
Same author

Long-term outcomes of Aurolab aqueous drainage implant in adults with refractory glaucoma.

The British journal of ophthalmology·2026
Same author

Efficacy of an Automated Point-of-Care Ultraviolet C Disinfection System for Reusable Ophthalmic Devices.

Ophthalmology·2026
Same author

Real-world efficacy, safety, and usability of a microvolume eyedrop delivery device in glaucoma: prospective randomized crossover trial.

Journal of cataract and refractive surgery·2025
Same author

Surgical Hand Antisepsis: How Can We Save Water?

American journal of ophthalmology·2025
Same author

Long-Term Follow-Up on a Juvenile Open-Angle Glaucoma Pedigree with a Novel EFEMP1 Mutation (c.1313, p.Tyr438Cys).

Ophthalmology. Glaucoma·2025
Same journal

Laser vision correction (LASIK, PRK, SMILE) with simultaneous accelerated corneal crosslinking.

Current opinion in ophthalmology·2026
Same journal

Traumatic macular hole: observe, operate, or other options.

Current opinion in ophthalmology·2026
Same journal

The evolving role of artificial intelligence in ophthalmology: basic science, translation, and clinical integration.

Current opinion in ophthalmology·2026
Same journal

Editorial: reducing risk for refractive surgery.

Current opinion in ophthalmology·2026
Same journal

Updates on Refractive Surgery: Benefits, Risks, and Costs of Modern Treatment Options.

Current opinion in ophthalmology·2026
Same journal

Corneal Allogeneic Intrastromal Ring Segments for keratoconus - recent evidence and the move to customized and custom shaped CAIRS.

Current opinion in ophthalmology·2026
See all related articles

Prostaglandin analogs are novel medications for lowering intraocular pressure in glaucoma. Recent studies clarify their mechanism, effectiveness, and safety, differentiating commonly used treatments.

Area of Science:

  • Ophthalmology
  • Pharmacology

Background:

  • Glaucoma is a leading cause of irreversible blindness worldwide.
  • Intraocular pressure (IOP) is a primary modifiable risk factor for glaucoma progression.
  • Prostaglandin analogs represent a significant advancement in IOP-lowering pharmacotherapy.

Purpose of the Study:

  • To review recent literature on prostaglandin analogs for glaucoma treatment.
  • To elucidate the mechanism of action, efficacy, and safety profiles of these agents.
  • To compare and contrast the three most frequently used once-daily prostaglandin analog medications.

Main Methods:

  • Comprehensive literature search of recent studies on prostaglandin analogs.
  • Analysis of data regarding mechanism of action, clinical efficacy, and adverse events.

Related Experiment Videos

  • Comparative assessment of commonly prescribed once-daily prostaglandin analogs.

    • Main Results:

    • Prostaglandin analogs effectively reduce intraocular pressure.
    • The primary mechanism involves enhancement of the uveoscleral outflow pathway.
    • Recent literature provides nuanced understanding of efficacy and safety, highlighting differences among agents.

    Conclusions:

    • Prostaglandin analogs are a cornerstone in the medical management of glaucoma.
    • Understanding the specific characteristics of each agent is crucial for optimal patient care.
    • Continued research refines the application and therapeutic potential of these medications.